Viewing StudyNCT02536625



Ignite Creation Date: 2024-05-06 @ 7:26 AM
Last Modification Date: 2024-10-26 @ 11:48 AM
Study NCT ID: NCT02536625
Status: COMPLETED
Last Update Posted: 2021-02-04
First Post: 2015-08-14

Brief Title: Study of the Impact of Everolimus Treatment on Lymphocytes NK Natural Killer Development and Functions for Patients With a Metastatic Breast Cancer HR HER2Neu Negative
Sponsor:
Organization: Centre Leon Berard

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 62
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Case-Control
Time Perspective List:

Clinical Trial Statuses

Name
31416
Who Masked List: